这是一篇来自已证抗体库的有关人类 PAK3的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PAK3 抗体。
PAK3 同义词: ARA; MRX30; MRX47; OPHN3; PAK-3; PAK3beta; bPAK; beta-PAK; serine/threonine-protein kinase PAK 3; adriamycin resistance-associated; oligophrenin-3; p21 (CDKN1A)-activated kinase 3; p21 protein (Cdc42/Rac)-activated kinase 3

赛默飞世尔
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 st1
赛默飞世尔 PAK3抗体(Biosource, 44-940G)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 st1). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫细胞化学; African green monkey; 1:150; 图 s8
赛默飞世尔 PAK3抗体(生活技术, 44940G)被用于被用于免疫细胞化学在African green monkey样品上浓度为1:150 (图 s8). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛默飞世尔 PAK3抗体(Invitrogen, 44940G)被用于被用于免疫印迹在人类样品上. Sci Adv (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000
赛默飞世尔 PAK3抗体(Invitrogen, 44940)被用于被用于免疫印迹在大鼠样品上浓度为1:1000. J Neurosci (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 4
赛默飞世尔 PAK3抗体(Invitrogen, 44940G)被用于被用于免疫印迹在人类样品上 (图 4). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500
赛默飞世尔 PAK3抗体(Invitrogen, 44940G)被用于被用于免疫印迹在小鼠样品上浓度为1:500. Neuropsychopharmacology (2014) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:100; 图 1
赛默飞世尔 PAK3抗体(Invitrogen, 44?C942G)被用于被用于免疫细胞化学在人类样品上浓度为1:100 (图 1). PLoS ONE (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 4
赛默飞世尔 PAK3抗体(Invitrogen, #44940G, lot #980627A)被用于被用于免疫印迹在小鼠样品上 (图 4). Development (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 3
赛默飞世尔 PAK3抗体(Invitrogen, 44-940G)被用于被用于免疫印迹在小鼠样品上 (图 3). Mol Neurobiol (2012) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图 3
赛默飞世尔 PAK3抗体(Invitrogen, 44-940G)被用于被用于免疫组化在小鼠样品上浓度为1:100 (图 3). J Neurosci (2010) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 1
  • 免疫组化-石蜡切片; 人类; 1:50; 图 6
赛默飞世尔 PAK3抗体(Biosource, 44-940G)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50 (图 1) 和 被用于免疫组化-石蜡切片在人类样品上浓度为1:50 (图 6). J Neurochem (2008) ncbi
兔 多克隆
赛默飞世尔 PAK3抗体(Biosource, 44-940G)被用于. J Neurosci (2007) ncbi
圣克鲁斯生物技术
小鼠 单克隆(A-6)
  • 免疫印迹; 小鼠; 图 5D
圣克鲁斯生物技术 PAK3抗体(Santa Cruz, sc-166887)被用于被用于免疫印迹在小鼠样品上 (图 5D). elife (2017) ncbi
小鼠 单克隆(D-8)
  • 免疫组化; 人类; 图 2a
  • 免疫印迹; 人类; 图 3b
圣克鲁斯生物技术 PAK3抗体(Santa Cruz Biotechnology, sc-166174)被用于被用于免疫组化在人类样品上 (图 2a) 和 被用于免疫印迹在人类样品上 (图 3b). Oncotarget (2016) ncbi
小鼠 单克隆(A-6)
  • 免疫印迹; 人类; 1:400
圣克鲁斯生物技术 PAK3抗体(Santa Cruz, sc-166887)被用于被用于免疫印迹在人类样品上浓度为1:400. PLoS ONE (2016) ncbi
小鼠 单克隆(A-6)
  • 免疫沉淀; 人类; 图 6
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 PAK3抗体(Santa Cruz Biotechnologies, sc-166887)被用于被用于免疫沉淀在人类样品上 (图 6) 和 被用于免疫印迹在人类样品上 (图 5). Blood (2015) ncbi
安迪生物R&D
羊 多克隆
  • 免疫组化-石蜡切片; 仓鼠; 1:80
  • 免疫细胞化学; 仓鼠; 1:50
  • 免疫印迹; 仓鼠
安迪生物R&D PAK3抗体(R&D Systems, AF6897)被用于被用于免疫组化-石蜡切片在仓鼠样品上浓度为1:80, 被用于免疫细胞化学在仓鼠样品上浓度为1:50 和 被用于免疫印迹在仓鼠样品上. Med Microbiol Immunol (2014) ncbi
赛信通(上海)生物试剂有限公司
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 s8
赛信通(上海)生物试剂有限公司 PAK3抗体(Cell Signalling, 2609)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s8). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫沉淀; 小鼠; 图 1
  • 免疫印迹; 小鼠; 1:1000; 图 1
赛信通(上海)生物试剂有限公司 PAK3抗体(Cell Signaling, 2609)被用于被用于免疫沉淀在小鼠样品上 (图 1) 和 被用于免疫印迹在小鼠样品上浓度为1:1000 (图 1). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 PAK3抗体(Cell Signaling Technology, 2609)被用于被用于免疫印迹在小鼠样品上. Oncotarget (2015) ncbi
文章列表
  1. Jeannot P, Nowosad A, Perchey R, Callot C, Bennana E, Katsube T, et al. p27Kip1 promotes invadopodia turnover and invasion through the regulation of the PAK1/Cortactin pathway. elife. 2017;6: pubmed 出版商
  2. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed 出版商
  3. Martin K, Pritchett J, Llewellyn J, Mullan A, Athwal V, Dobie R, et al. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis. Nat Commun. 2016;7:12502 pubmed 出版商
  4. Yuan W, Guo Y, Li X, Deng M, Shen Z, Bo C, et al. MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway. Oncotarget. 2016;7:60230-60244 pubmed 出版商
  5. Reinhard J, Kriz A, Galic M, Angliker N, Rajalu M, Vogt K, et al. The calcium sensor Copine-6 regulates spine structural plasticity and learning and memory. Nat Commun. 2016;7:11613 pubmed 出版商
  6. Wang Y, Gratzke C, Tamalunas A, Wiemer N, Ciotkowska A, Rutz B, et al. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate. PLoS ONE. 2016;11:e0153312 pubmed 出版商
  7. Hahn C, Scott D, Xu X, Roda M, Payne G, Wells J, et al. The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability. Sci Adv. 2015;1: pubmed
  8. Singh N, Kotla S, Dyukova E, Traylor J, Orr A, Chernoff J, et al. Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice. Nat Commun. 2015;6:7450 pubmed 出版商
  9. Briz V, Zhu G, Wang Y, Liu Y, Avetisyan M, Bi X, et al. Activity-dependent rapid local RhoA synthesis is required for hippocampal synaptic plasticity. J Neurosci. 2015;35:2269-82 pubmed 出版商
  10. Chow H, Dong B, Duron S, Campbell D, Ong C, Hoeflich K, et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6:1981-94 pubmed
  11. Badolia R, Manne B, Dangelmaier C, Chernoff J, Kunapuli S. Gq-mediated Akt translocation to the membrane: a novel PIP3-independent mechanism in platelets. Blood. 2015;125:175-84 pubmed 出版商
  12. Meng G, Tian C, Wang H, Xu Y, Zhang B, Shi Q, et al. Remarkable reductions of PAKs in the brain tissues of scrapie-infected rodent possibly linked closely with neuron loss. Med Microbiol Immunol. 2014;203:291-302 pubmed 出版商
  13. De Filippis B, Nativio P, Fabbri A, Ricceri L, Adriani W, Lacivita E, et al. Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome. Neuropsychopharmacology. 2014;39:2506-18 pubmed 出版商
  14. Itakura A, Aslan J, Kusanto B, Phillips K, Porter J, Newton P, et al. p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophils. PLoS ONE. 2013;8:e73063 pubmed 出版商
  15. Sipe C, Liu L, Lee J, Grimsley Myers C, Lu X. Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization. Development. 2013;140:1785-95 pubmed 出版商
  16. Jafari M, Seese R, Babayan A, Gall C, Lauterborn J. Glucocorticoid receptors are localized to dendritic spines and influence local actin signaling. Mol Neurobiol. 2012;46:304-15 pubmed 出版商
  17. Chen L, Rex C, Babayan A, Kramar E, Lynch G, Gall C, et al. Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J Neurosci. 2010;30:10977-84 pubmed 出版商
  18. Nguyen T, Galvan V, Huang W, Banwait S, Tang H, Zhang J, et al. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem. 2008;104:1065-80 pubmed
  19. Chen L, Rex C, Casale M, Gall C, Lynch G. Changes in synaptic morphology accompany actin signaling during LTP. J Neurosci. 2007;27:5363-72 pubmed